Crystal Strickland
Obstetrics & Gynecology · Valparaiso, INNPI 1700947462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 31.4% of the total.
Across 199 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Hologic Sales And Service, LLC$456
- Astellas Pharma US Inc$335
- Coopersurgical, Inc.$273
- Sumitomo Pharma America, Inc.$215
- Pfizer$177
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,75598%
- Education$782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 78 | $1,205 |
| Hologic Sales And Service, LLC | 10 | $456 |
| Astellas Pharma US Inc | 13 | $335 |
| Coopersurgical, Inc. | 10 | $273 |
| Sumitomo Pharma America, Inc. | 10 | $215 |
| Pfizer | 9 | $177 |
| Agile Therapeutics, Inc. | 7 | $153 |
| Exeltis, USA Inc. | 8 | $139 |
| Therapeuticsmd, Inc. | 5 | $87 |
| Mayne Pharma Commercial LLC | 5 | $85 |
| AMAG Pharmaceuticals, Inc. | 5 | $78 |
| Merck | 4 | $57 |
| Avion Pharmaceuticals | 3 | $56 |
| Johnson & Johnson | 2 | $52 |
| Myovant Sciences Inc. | 4 | $50 |
| Shield Therapeutics Inc | 3 | $43 |
| Pacira Pharmaceuticals Incorporated | 2 | $43 |
| Organon | 2 | $39 |
| Lupin Inc. | 3 | $39 |
| Biogen | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Mylan Pharmaceuticals Inc. | 2 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Boston Scientific | 1 | $18 |
| Medicem Inc. | 1 | $18 |
| Millicent US Inc | 1 | $18 |
| Bayer | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Hologic Inc | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Dysis Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,833 in reported general payments places this provider in the 85th percentile of 743 obstetrics & gynecology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 43 | $3,206 |
| ProgesteroneProgesterone, Micronized | 41 | $2,010 |
| Estradiol (Twice Weekly)Estradiol | 19 | $1,601 |
| Estradiol (Once Weekly)Estradiol | 15 | $1,349 |
| Alendronate Sodium | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Valparaiso
- Jeannette Colon-MarinValparaiso$13K
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Enrique InfanteElkhart$41K
- Paul MorrisonNewburgh$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.